ELVN

ELVN Other Income/Expenses (Net)

$18.49MTTM · USD

Period ending:

ELVN FY Other Income/Expenses (Net)USD
ELVN FY Other Income/Expenses (Net)2017-12-31: $9.13M2018-12-31: -$660.00K2019-12-31: $653.00K2020-12-31: -$9.65M2021-12-31: $22.00K2022-12-31: $1.13M2023-12-31: $11.95M2024-12-31: $15.76M2025-12-31: $15.96M$15.96M-$9.65M
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ELVN other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Enliven Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
15,964,000
15,762,000
11,945,000
1,129,000
22,000
-9,648,000
653,000
-660,000
9,126,000

Compare other income/expenses (net)

All ELVN financial metrics · ELVN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.